Goncalves Tasca B, Mganga A, Leung C, Shilugu L, Pell C, Onjare B
PLOS Glob Public Health. 2024; 4(8):e0002795.
PMID: 39116120
PMC: 11309415.
DOI: 10.1371/journal.pgph.0002795.
Baye T, Kassaw A, Gebrie D, Girmaw F, Ashagrie G
BMJ Open. 2024; 14(5):e081767.
PMID: 38724061
PMC: 11086473.
DOI: 10.1136/bmjopen-2023-081767.
Farhat M, Cox H, Ghanem M, Denkinger C, Rodrigues C, Abd El Aziz M
Nat Rev Microbiol. 2024; 22(10):617-635.
PMID: 38519618
DOI: 10.1038/s41579-024-01025-1.
Wagnew F, Gray D, Tsheten T, Kelly M, Clements A, Alene K
Nutr Rev. 2023; 82(9):1216-1225.
PMID: 37759339
PMC: 11317773.
DOI: 10.1093/nutrit/nuad120.
Jerene D, Levy J, van Kalmthout K, van Rest J, McQuaid C, Quaife M
BMJ Open. 2023; 13(3):e068685.
PMID: 36918242
PMC: 10016242.
DOI: 10.1136/bmjopen-2022-068685.
In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence: A Randomized Noninferiority Trial.
Burzynski J, Mangan J, Lam C, Macaraig M, Salerno M, deCastro B
JAMA Netw Open. 2022; 5(1):e2144210.
PMID: 35050357
PMC: 8777548.
DOI: 10.1001/jamanetworkopen.2021.44210.
Improving Treatment Adherence with Integrated Patient Management for TB Patients in Morocco.
Park S, Moon N, Oh B, Park M, Kang K, Sentissi I
Int J Environ Res Public Health. 2021; 18(19).
PMID: 34639291
PMC: 8507615.
DOI: 10.3390/ijerph18199991.
Evidence of Nonadherence in Cases of Pseudoresistant Hypertension.
Zanatta J, Cosenso-Martin L, da Silva Lopes V, Uyemura J, Polegati Santos A, Paz Landim M
Integr Blood Press Control. 2021; 14:9-17.
PMID: 33603455
PMC: 7887157.
DOI: 10.2147/IBPC.S264057.
Treatment outcomes of drug susceptible Tuberculosis in private health facilities in Lagos, South-West Nigeria.
Oladimeji O, Adepoju V, Anyiam F, San J, Odugbemi B, Hyera F
PLoS One. 2021; 16(1):e0244581.
PMID: 33471851
PMC: 7816975.
DOI: 10.1371/journal.pone.0244581.
HIV and the tuberculosis "set point": how HIV impairs alveolar macrophage responses to tuberculosis and sets the stage for progressive disease.
Auld S, Staitieh B
Retrovirology. 2020; 17(1):32.
PMID: 32967690
PMC: 7509826.
DOI: 10.1186/s12977-020-00540-2.
Synchronous and asynchronous video observed therapy (VOT) for tuberculosis treatment adherence monitoring and support.
Garfein R, Doshi R
J Clin Tuberc Other Mycobact Dis. 2019; 17:100098.
PMID: 31867442
PMC: 6904830.
DOI: 10.1016/j.jctube.2019.100098.
Identification of Anti-Mycobacterial Biofilm Agents Based on the 2-Aminoimidazole Scaffold.
Nguyen T, Minrovic B, Melander R, Melander C
ChemMedChem. 2019; 14(9):927-937.
PMID: 30834698
PMC: 6682311.
DOI: 10.1002/cmdc.201900033.
Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.
Story A, Aldridge R, Smith C, Garber E, Hall J, Ferenando G
Lancet. 2019; 393(10177):1216-1224.
PMID: 30799062
PMC: 6429626.
DOI: 10.1016/S0140-6736(18)32993-3.
The historical experience and practice of fight against tuberculosis in country which is one of the high drug resistant-tuberculosis (DR-TB) burden countries in European Union (EU).
Korablioviene J, Mauricas M, Caplinskas S, Zagrebneviene G, Korabliov P
J Prev Med Hyg. 2019; 59(4):E328-E335.
PMID: 30656237
PMC: 6319128.
DOI: 10.15167/2421-4248/jpmh2018.59.4.926.
Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities.
Subbaraman R, De Mondesert L, Musiimenta A, Pai M, Mayer K, Thomas B
BMJ Glob Health. 2018; 3(5):e001018.
PMID: 30364330
PMC: 6195152.
DOI: 10.1136/bmjgh-2018-001018.
Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.
Alipanah N, Jarlsberg L, Miller C, Linh N, Falzon D, Jaramillo E
PLoS Med. 2018; 15(7):e1002595.
PMID: 29969463
PMC: 6029765.
DOI: 10.1371/journal.pmed.1002595.
Evaluation of the Directly Observed Treatment's Acceptance by Tuberculosis Patients in the Republic of Macedonia.
Ilievska-Poposka B, Zakoska M, Mitreski V
Open Access Maced J Med Sci. 2018; 6(5):896-900.
PMID: 29875868
PMC: 5985883.
DOI: 10.3889/oamjms.2018.204.
Outpatient directly observed therapy for hepatitis C among people who use drugs: a systematic review and meta-analysis.
McDermott C, Lockhart C, Devine B
J Virus Erad. 2018; 4(2):118-122.
PMID: 29682305
PMC: 5892673.
Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.
Patel E, Solomon S, McFall A, Srikrishnan A, Pradeep A, Nandagopal P
Int J Drug Policy. 2018; 57:51-60.
PMID: 29679811
PMC: 5994190.
DOI: 10.1016/j.drugpo.2018.03.023.
Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis.
Liu X, Blaschke T, Thomas B, de Geest S, Jiang S, Gao Y
Int J Environ Res Public Health. 2017; 14(10).
PMID: 28946683
PMC: 5664616.
DOI: 10.3390/ijerph14101115.
